Skip to content

Effects of brain-computer interface technology for upper limb function and attention in stroke patients

Effects of brain-computer interface technology for upper limb function and attention in stroke patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050430
Enrollment
Unknown
Registered
2021-08-27
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke hemiplegia

Interventions

Group B:Routine rehabilitation+Brain-machine interface

Sponsors

Hebei General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis of stroke conforms to the diagnostic criteria for stroke formulated by the Fourth National Cerebrovascular Disease Conference, and is confirmed by imaging examinations such as head CT or MRI; 2. Aged 18-65 years; 3. The first onset, within one month of onset, unilateral lesions, (upper limb Brunnstrom stage: stage III-V, muscle tone modified Ashworth grade = 27 points; 6. The subjects have not received formal motor imagery treatment before the clinical trial. After being assessed by the Kinesiology-Visual Imagination Questionnaire (KVIQ), the subjects have a certain ability of motor imagery; 7. The vital signs are stable, and there are no obvious contraindications to rehabilitation training; 8. Informed consent was obtained for the disease and treatment plan, and the informed consent was signed.

Exclusion criteria

Exclusion criteria: 1. Patients with epilepsy, active bleeding, malignant tumor, severe heart, liver, lung, kidney, endocrine, hematopoiesis, immune system and other serious primary diseases; 2. Those who have limb dysfunction caused by other reasons before the onset of the disease or who have recently suffered from upper limb fractures, severe arthritis, joint replacement, etc. that affect the function of the upper limbs; 3. Those with other musculoskeletal and neurological diseases that affect functional recovery; 4. There is a metal implant in the skull, a metal pacemaker is worn, or the patient's skull is incomplete; 5. Skin damage or infection at the contact part of the upper limbs with the electrode pads or allergic to the electrode pads; 6. The investigator judges that the patient has poor compliance and cannot complete the study as required; 7. Participating in other interventional studies.

Design outcomes

Primary

MeasureTime frame
Fugl-meyer Motor Function Scale * Upper limb (FMA);Modified Barthel Index (MBI);Wolf Motor Function Evaluation Scale;Attention Network Test (ANT);Test of Everyday Attention,TEA;

Countries

China

Contacts

Public ContactYin Yu

Hebei General Hospital

yinyu-99@163.com+86 15532139227

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026